ArticleMolecular medicine reports2020

SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo.

Qiu-Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.